COMMUNIQUÉS West-GlobeNewswire

Integrated Cannabis Company Provides Corporate Update
27/03/2019
VANCOUVER, British Columbia, March 27, 2019 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“ Integrated Cannabis ” or the “ Company ”), is pleased to provide a corporate update. The [...]
Progressive Care to Host Conference Call on the 2018 Annual Report and Business Update on March 28, 2019
27/03/2019
MIAMI, March 27, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference [...]
Biotricity Achieves Market Expansion in Two New States
27/03/2019
REDWOOD CITY, Calif., March 27, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. ( OTCQB : BTCY ), a medical diagnostic and consumer healthcare technology company, has expanded its sales team to cover two additional states in [...]
Guardant Health Announces Definitive Agreement to Acquire Bellwether Bio
27/03/2019
REDWOOD CITY, Calif., March 27, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), announced that it has entered into a definitive agreement to acquire Bellwether Bio, Inc., a privately held company focused on [...]
Imvax to Present Results from Phase 1b Clinical Trial of IGV-001 in Glioblastoma Multiforme at the American Association for Cancer Research Annual Meeting 2019
27/03/2019
PHILADELPHIA, March 27, 2019 (GLOBE NEWSWIRE) -- Imvax, Inc., a clinical-stage biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies, announced today that [...]
Todos Medical Appoints Dr. Colin Bier to Its Board of Directors
27/03/2019
REHOVOT, Israel, March 27, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and [...]
Veritas Pharma Provides Corporate Update
27/03/2019
VANCOUVER, British Columbia, March 27, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce corporate highlights and to communicate [...]
CymaBay Therapeutics Announces Multiple Presentations During The International Liver Conference™ 2019
27/03/2019
Oral presentation will feature clinical data for seladelpar in primary biliary cholangitis (PBC) patients with cirrhosis NEWARK, Calif., March 27, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), today [...]
Precipio Receives Expected Delisting Determination from Nasdaq Staff and Will Request Nasdaq Hearing
27/03/2019
NEW HAVEN, Conn., March 27, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) today announced that it has received the expected delisting determination from Nasdaq Staff. The Company [...]
MediPharm Labs Sets Date to Release Fourth Quarter and Full Year 2018 Financial Results
27/03/2019
TORONTO, March 27, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, [...]
NEOVACS STRENGTHENS ITS FINANCIAL STRUCTURE: ISSUANCE OF "ORNANE" FOR A MAXIMUM AMOUNT OF €10M, WITHOUT STOCK SUBSCRIPTION WARRANTS
27/03/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE N E OVACS STRENGTHENS ITS FINANCIAL STRUCTURE: ISSUANCE OF "ORNANE" FOR A MAXIMUM AMOUNT OF €10M, WITHOUT STOCK SUBSCRIPTION WARRANTS Paris and Boston, March 25 th 2019 - 7: [...]
BioCorRx Promotes Dr. Balbir S. Brar to Senior VP of Drug Development; Extends Service Agreement
27/03/2019
ANAHEIM, CA, March 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTC: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of substance abuse disorders, today [...]
Bellicum Pharmaceuticals to Participate in Jefferies 6th Annual IO Cell Therapy Summit
27/03/2019
HOUSTON, March 27, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) , a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Affimed Reports 2018 Financial Results and Operational Progress
27/03/2019
- AFM13: Encouraging data supports initiation of monotherapy registration-directed study in first half of 2019; Combination study with cord blood-derived natural killer cells planned to initiate at MD Anderson; Clinical [...]
Fibrocell Announces Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-007
27/03/2019
- Phase 3 clinical trial, named DEFI-RDEB, is expected to commence in the second quarter of 2019 - - Additional data from Phase 1/2 clinical trial demonstrates FCX-007 continues to be well tolerated with continued [...]
Centrexion Therapeutics Announces Publication of Phase 2 Efficacy Data on CNTX-4975 for Treatment of Moderate to Severe Knee Osteoarthritis Pain in Arthritis & Rheumatology
27/03/2019
BOSTON, March 27, 2019 (GLOBE NEWSWIRE) -- Centrexion Therapeutics Corporation (Centrexion) , a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain, today announced [...]
Assembly Biosciences Announces Multiple Abstracts Highlighting HBV Core Inhibitor Portfolio Accepted for Oral and Poster Presentations at EASL 2019
27/03/2019
SAN FRANCISCO, March 27, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases [...]
Dermavant Sciences Announces Appointment of Cyril Allouche as Chief Financial Officer and Provides Recent Corporate Update
27/03/2019
Mr. Allouche has over 20 years of combined experience in finance leadership, audit, and advisory roles, most recently serving as Principal Accounting Officer, Head of Finance, and Corporate Controller at Revance [...]
Supreme Cannabis Scales Up Production & Into Higher Margin Product Lines -- CFN Media
27/03/2019
SEATTLE, March 27, 2019 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article featuring [...]

Pages